1
/
of
0
FDA Drug Approval, N018267, FUROSEMIDE
FDA Drug Approval, N018267, FUROSEMIDE
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
NDA: 018267
Company: HIKMA
Drug Name: FUROSEMIDE
Active Ingredients: FUROSEMIDE
Strength: INJECTABLE;INJECTION
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification:
Company: HIKMA
Drug Name: FUROSEMIDE
Active Ingredients: FUROSEMIDE
Strength: INJECTABLE;INJECTION
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification:
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details